BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27332121)

  • 21. Atomic view of the energy landscape in the allosteric regulation of Abl kinase.
    Saleh T; Rossi P; Kalodimos CG
    Nat Struct Mol Biol; 2017 Nov; 24(11):893-901. PubMed ID: 28945248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl.
    Bhatt VS; Zeng D; Krieger I; Sacchettini JC; Cho JH
    Biophys J; 2016 Jun; 110(12):2630-2641. PubMed ID: 27332121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic Insights into the Binding between the nSH3 Domain of CrkII and Proline-Rich Motifs in cAbl.
    Zeng D; Bhatt VS; Shen Q; Cho JH
    Biophys J; 2016 Nov; 111(9):1843-1853. PubMed ID: 27806266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Entropy Hotspots for the Binding of Intrinsically Disordered Ligands to a Receptor Domain.
    Shi J; Shen Q; Cho JH; Hwang W
    Biophys J; 2020 May; 118(10):2502-2512. PubMed ID: 32311315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamic contribution of backbone conformational entropy in the binding between SH3 domain and proline-rich motif.
    Zeng D; Shen Q; Cho JH
    Biochem Biophys Res Commun; 2017 Feb; 484(1):21-26. PubMed ID: 28111343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
    Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
    BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
    McDonald CB; Seldeen KL; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Processing of X-ray diffraction data collected in oscillation mode.
    Otwinowski Z; Minor W
    Methods Enzymol; 1997; 276():307-26. PubMed ID: 27754618
    [No Abstract]   [Full Text] [Related]  

  • 29. Tracking cancer drugs in living cells by thermal profiling of the proteome.
    Savitski MM; Reinhard FB; Franken H; Werner T; Savitski MF; Eberhard D; Martinez Molina D; Jafari R; Dovega RB; Klaeger S; Kuster B; Nordlund P; Bantscheff M; Drewes G
    Science; 2014 Oct; 346(6205):1255784. PubMed ID: 25278616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
    Xue Y; Yuwen T; Zhu F; Skrynnikov NR
    Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water networks contribute to enthalpy/entropy compensation in protein-ligand binding.
    Breiten B; Lockett MR; Sherman W; Fujita S; Al-Sayah M; Lange H; Bowers CM; Heroux A; Krilov G; Whitesides GM
    J Am Chem Soc; 2013 Oct; 135(41):15579-84. PubMed ID: 24044696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary conservation of the polyproline II conformation surrounding intrinsically disordered phosphorylation sites.
    Elam WA; Schrank TP; Campagnolo AJ; Hilser VJ
    Protein Sci; 2013 Apr; 22(4):405-17. PubMed ID: 23341186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A propensity scale for type II polyproline helices (PPII): aromatic amino acids in proline-rich sequences strongly disfavor PPII due to proline-aromatic interactions.
    Brown AM; Zondlo NJ
    Biochemistry; 2012 Jun; 51(25):5041-51. PubMed ID: 22667692
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.